CareDx PE Ratio 2013-2024 | CDNA

Current and historical p/e ratio for CareDx (CDNA) from 2013 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. CareDx PE ratio as of May 13, 2025 is 14.23.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

CareDx PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2025-05-13 16.13 15.81
2024-12-31 21.41 $1.02 20.99
2024-09-30 31.23 $-2.70 0.00
2024-06-30 15.53 $-2.99 0.00
2024-03-31 10.59 $-3.42 0.00
2023-12-31 12.00 $-3.54 0.00
2023-09-30 7.00 $-1.67 0.00
2023-06-30 8.50 $-1.56 0.00
2023-03-31 9.14 $-1.51 0.00
2022-12-31 11.41 $-1.44 0.00
2022-09-30 17.02 $-1.41 0.00
2022-06-30 21.48 $-1.32 0.00
2022-03-31 36.99 $-0.95 0.00
2021-12-31 45.48 $-0.59 0.00
2021-09-30 63.37 $-0.35 0.00
2021-06-30 91.52 $-0.18 0.00
2021-03-31 68.09 $-0.29 0.00
2020-12-31 72.45 $-0.42 0.00
2020-09-30 37.94 $-0.46 0.00
2020-06-30 35.43 $-0.44 0.00
2020-03-31 21.83 $-0.48 0.00
2019-12-31 21.57 $-0.52 0.00
2019-09-30 22.61 $-0.50 0.00
2019-06-30 35.99 $-1.00 0.00
2019-03-31 31.52 $-1.21 0.00
2018-12-31 25.14 $-1.33 0.00
2018-09-30 28.85 $-2.37 0.00
2018-06-30 12.24 $-2.46 0.00
2018-03-31 7.97 $-2.25 0.00
2017-12-31 7.34 $-2.21 0.00
2017-09-30 3.70 $-1.81 0.00
2017-06-30 1.11 $-1.44 0.00
2017-03-31 1.40 $-2.01 0.00
2016-12-31 2.70 $-2.56 0.00
2016-09-30 3.55 $-2.23 0.00
2016-06-30 4.31 $-2.26 0.00
2016-03-31 4.96 $-1.77 0.00
2015-12-31 6.40 $-1.15 0.00
2015-09-30 4.17 $-0.75 0.00
2015-06-30 6.50 $-0.34 0.00
Sector Industry Market Cap Revenue
Medical Medical Services $0.911B $0.334B
CareDx, Inc. is a commercial stage company. It develops, markets, and delivers a diagnostic surveillance solution for heart transplant recipients. The Company provides AlloMap, a noninvasive blood test used to aid in the identification of heart transplant recipients. It is also pursuing other areas of transplant surveillance, such as the use of cell-free DNA (cfDNA) as a biomarker for rejection. CareDx, Inc. is based in Brisbane, California.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $143.728B 26.96
Elevance Health (ELV) United States $94.145B 12.15
CVS Health (CVS) United States $81.986B 10.19
Cencora (COR) United States $53.983B 18.77
Natera (NTRA) United States $21.477B 0.00
DiDi Global (DIDIY) China $21.462B 32.57
BioMerieux (BMXMF) France $15.263B 0.00
Solventum (SOLV) United States $12.941B 13.70
EUROFINS SCIENT (ERFSF) Luxembourg $12.036B 0.00
Revvity (RVTY) United States $11.610B 19.98
Doximity (DOCS) United States $11.396B 59.26
ICON (ICLR) Ireland $11.324B 10.53
CochLear (CHEOY) Australia $11.195B 0.00
Viatris (VTRS) United States $10.516B 3.61
Medpace Holdings (MEDP) United States $9.017B 23.95
Avantor (AVTR) United States $8.859B 12.87
HealthEquity (HQY) United States $8.361B 41.13
Sonic Healthcare (SKHHY) Australia $8.215B 0.00
Charles River Laboratories (CRL) United States $7.027B 13.77
Amplifon S.p.A (AMFPF) Italy $4.966B 26.21
Bausch + Lomb (BLCO) Canada $4.202B 24.77
BrightSpring Health Services (BTSG) United States $3.894B 36.05
Sotera Health (SHC) United States $3.832B 21.77
Surgery Partners (SGRY) United States $2.982B 38.77
Alignment Healthcare (ALHC) United States $2.952B 0.00
Concentras Parent (CON) United States $2.771B 16.01
Organon (OGN) United States $2.264B 2.41
Ardent Health Partners (ARDT) United States $2.121B 9.04
Premier (PINC) United States $2.101B 14.38
Progyny (PGNY) United States $1.886B 41.51
PACS (PACS) United States $1.698B 0.00
GeneDx Holdings (WGS) United States $1.683B 64.83
GoodRx Holdings (GDRX) United States $1.669B 31.07
Teladoc Health (TDOC) United States $1.289B 0.00
Pediatrix Medical (MD) United States $1.234B 9.39
Agilon Health (AGL) United States $1.229B 0.00
Establishment Labs Holdings (ESTA) $1.000B 0.00
Ryman Healthcare (RYHTY) New Zealand $0.998B 0.00
AMN Healthcare Services Inc (AMN) United States $0.866B 8.11
Embecta (EMBC) United States $0.725B 4.89
QDM (QDMI) Hong Kong, SAR China $0.690B 0.00
Nutex Health (NUTX) United States $0.689B 13.50
Enhabit (EHAB) United States $0.530B 43.58
InnovAge Holding (INNV) United States $0.513B 0.00
Auna S.A (AUNA) Luxembourg $0.513B 13.59
Sonida Senior Living (SNDA) United States $0.512B 0.00
LifeMD (LFMD) United States $0.389B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.363B 0.00
SBC Medicals (SBC) United States $0.359B 0.00
Beauty Health (SKIN) United States $0.220B 0.00
Performant Healthcare (PHLT) United States $0.202B 0.00
Oncology Institute (TOI) United States $0.193B 0.00
DocGo (DCGO) United States $0.147B 24.08
Sera Prognostics (SERA) United States $0.087B 0.00
So-Young (SY) China $0.087B 0.00
Basel Medical Group (BMGL) Singapore $0.087B 0.00
KindlyMD (KDLY) United States $0.082B 0.00
OncoCyte (OCX) United States $0.080B 0.00
Ascend Wellness Holdings (AAWH) United States $0.076B 0.00
NeueHealth (NEUE) United States $0.061B 0.00
IceCure Medical (ICCM) Israel $0.054B 0.00
Biodesix (BDSX) United States $0.053B 0.00
Pheton Holdings (PTHL) China $0.031B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.030B 0.00
ModivCare (MODV) United States $0.018B 0.00
SeaStar Medical Holding (ICU) United States $0.012B 0.00
Co-Diagnostics (CODX) United States $0.011B 0.00
Intelligent Bio Solutions (INBS) United States $0.008B 0.00
BioNexus Gene Lab (BGLC) $0.006B 0.00
XWELL (XWEL) United States $0.005B 0.00
Aclarion (ACON) United States $0.004B 0.00
ISpecimen (ISPC) United States $0.003B 0.00
INVO Fertility (IVF) United States $0.002B 0.00
NewGenIvf Group (NIVF) Thailand $0.002B 0.00
Cano Health (CANOQ) United States $0.000B 0.00